Carcinogenesis, Vol. 23, No. 11, 1953-1960,
November 2002
© 2002 Oxford University Press
CARCINOGENESIS |
Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats
Department of Pharmacology, University of Florence, 6 Viale Pieraccini, 50139 Florence,
1 Department of Pathology, S.M.Annunziata Hospital, Florence,
2 Department of Statistics, University of Florence, 59 Viale Morgagni 50134 Florence, Italy,
3 Department of Microbiology, U.C.C., Cork, Ireland and
4 Department of Human Pathology and Oncology, University of Florence, Italy
Prebiotics such as fructans, and probiotics such as Lactobacilli or Bifidobacteria, or a combination of prebiotics and probiotics (synbiotics) are thought to be protective against colon cancer. Therefore, we studied whether the prebiotic inulin enriched with oligofructose (Raftilose-Synergy1®, briefly, Synergy1, 10% of the diet), probiotics [Bifidobacterium lactis (Bb12) and Lactobacillus rhamnosus (LGG), each at 5x108 c.f.u./g diet] or synbiotics (a combination of the two) protect rats against azoxymethane (AOM)-induced colon cancer. Male F344 rats were divided into: Controls; PRE, which were fed a diet containing Synergy1; PRO, fed a diet containing LGG and Bb12; PREPRO, fed a diet containing Synergy1, LGG and BB12. Ten days after beginning the diets, rats were treated with AOM (15 mg/kg s.c. two times); dietary treatments were continued for the entire experiment. Thirty-one weeks after AOM, rats treated with Synergy1 (PRE and PREPRO groups) had a significantly lower (P < 0.001) number of tumours (adenomas and cancers) than rats without Synergy1 (colorectal tumours/rat were 1.9 ± 1.7, 1.1 ± 1.1, 2.2 ± 1.4 and 0.9 ± 1.2 in Controls, PRE, PRO and PREPRO groups, respectively, means ± SD). A slight, not significant effect of probiotics in reducing malignant tumours was also observed (P = 0.079). Caecal short-chain fatty acids (SCFA) were higher (P < 0.001) in the groups treated with Synergy1. Apoptosis was increased in the normal mucosa of the PRO group, while no variation was observed in the tumours. Colonic proliferation was lower in the PRE group as compared with Controls. Glutathione S-transferase placental enzyme pi type expression, and to a lesser extent, inducible NO synthase were depressed in the tumours from rats in the PRE and PREPRO groups. Cycloxygenase-2 expression was increased in the tumours of control rats but not in those from PRE, PRO or PREPRO rats. In conclusion, prebiotic administration in the diet decreases AOM-induced carcinogenesis in rats.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Seifert and B. Watzl Inulin and Oligofructose: Review of Experimental Data on Immune Modulation J. Nutr., November 1, 2007; 137(11): 2563S - 2567S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Pool-Zobel and J. Sauer Overview of Experimental Data on Reduction of Colorectal Cancer Risk by Inulin-Type Fructans J. Nutr., November 1, 2007; 137(11): 2580S - 2584S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Tuohy Inulin-Type Fructans in Healthy Aging J. Nutr., November 1, 2007; 137(11): 2590S - 2593S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nagae, A. Tsuchiya, T. Katayama, K. Yamamoto, S. Wakatsuki, and R. Kato Structural Basis of the Catalytic Reaction Mechanism of Novel 1,2-{alpha}-L-Fucosidase from Bifidobacterium bifidum J. Biol. Chem., June 22, 2007; 282(25): 18497 - 18509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Collado, J. Meriluoto, and S. Salminen Development of New Probiotics by Strain Combinations: Is It Possible to Improve the Adhesion to Intestinal Mucus? J Dairy Sci, June 1, 2007; 90(6): 2710 - 2716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rafter, M. Bennett, G. Caderni, Y. Clune, R. Hughes, P. C Karlsson, A. Klinder, M. O'Riordan, G. C O'Sullivan, B. Pool-Zobel, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients Am. J. Clinical Nutrition, February 1, 2007; 85(2): 488 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lesniewska, I. Rowland, P. D. Cani, A. M. Neyrinck, N. M. Delzenne, and P. J. Naughton Effect on Components of the Intestinal Microflora and Plasma Neuropeptide Levels of Feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and Inulin to Adult and Elderly Rats. Appl. Envir. Microbiol., October 1, 2006; 72(10): 6533 - 6538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bauer-Marinovic, S. Florian, K. Muller-Schmehl, H. Glatt, and G. Jacobasch Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon Carcinogenesis, September 1, 2006; 27(9): 1849 - 1859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Roy, C. L. Kien, L. Bouthillier, and E. Levy Short-Chain Fatty Acids: Ready for Prime Time? Nutr Clin Pract, August 1, 2006; 21(4): 351 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Van Loo, D. Bosscher, and A. Franck Experimental modulation of cancer risk factors by prebiotic oligofructose enriched inulin (Synergy1) is confirmed in human volunteers FASEB J, March 1, 2006; 20(5): A994 - A994.
|
|
|
|
|
|
A. Dinoto, A. Suksomcheep, S. Ishizuka, H. Kimura, S. Hanada, Y. Kamagata, K. Asano, F. Tomita, and A. Yokota Modulation of Rat Cecal Microbiota by Administration of Raffinose and Encapsulated Bifidobacterium breve Appl. Envir. Microbiol., January 1, 2006; 72(1): 784 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Lesniewska, I Rowland, H. N Laerke, G Grant, and P. J Naughton Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo Exp Physiol, January 1, 2006; 91(1): 229 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujita, F. Oura, N. Nagamine, T. Katayama, J. Hiratake, K. Sakata, H. Kumagai, and K. Yamamoto Identification and Molecular Cloning of a Novel Glycoside Hydrolase Family of Core 1 Type O-Glycan-specific Endo-{alpha}-N-acetylgalactosaminidase from Bifidobacterium longum J. Biol. Chem., November 11, 2005; 280(45): 37415 - 37422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Le Leu, I. L. Brown, Y. Hu, A. R. Bird, M. Jackson, A. Esterman, and G. P. Young A Synbiotic Combination of Resistant Starch and Bifidobacterium lactis Facilitates Apoptotic Deletion of Carcinogen-Damaged Cells in Rat Colon J. Nutr., May 1, 2005; 135(5): 996 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kameue, T. Tsukahara, K. Yamada, H. Koyama, Y. Iwasaki, K. Nakayama, and K. Ushida Dietary Sodium Gluconate Protects Rats from Large Bowel Cancer by Stimulating Butyrate Production J. Nutr., April 1, 2004; 134(4): 940 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Mutch, P. Anderle, M. Fiaux, R. Mansourian, K. Vidal, W. Wahli, G. Williamson, and M.-A. Roberts Regional variations in ABC transporter expression along the mouse intestinal tract Physiol Genomics, March 12, 2004; 17(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Femia, P. Dolara, and G. Caderni Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis Carcinogenesis, February 1, 2004; 25(2): 277 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roller, G. Rechkemmer, and B. Watzl Prebiotic Inulin Enriched with Oligofructose in Combination with the Probiotics Lactobacillus rhamnosus and Bifidobacterium lactis Modulates Intestinal Immune Functions in Rats J. Nutr., January 1, 2004; 134(1): 153 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara Identification of Mucin-depleted Foci in the Unsectioned Colon of Azoxymethane-treated Rats: Correlation with Carcinogenesis Cancer Res., May 15, 2003; 63(10): 2388 - 2392. [Abstract] [Full Text] [PDF]
|
|